ACE and metabolic dysfunction-associated steatotic liver disease: When the ACE gene polymorphism was evaluated, the ACE genotypes were as follows: D/D (41.9%), I/I (32.2%), D/I (6.4%), I/D (19.3%) in the NAFLD group and D/D (57.5%), I/I (7.5%), D/I (15%), I/D (10%) in the control group.